An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)

NCT01769456 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

BEHAVIORAL: PCC
DRUG: Emtricitabine/tenofovir (FTC/TDF (Truvada®))

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]
[object Object]